Boston Family Office LLC lessened its position in shares of Stericycle Inc (NASDAQ:SRCL) by 5.7% in the 4th quarter, Holdings Channel reports. The institutional investor owned 98,415 shares of the business services provider’s stock after selling 5,959 shares during the period. Boston Family Office LLC’s holdings in Stericycle were worth $6,691,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in the company. Sentry Investment Management LLC raised its stake in shares of Stericycle by 1.1% during the 2nd quarter. Sentry Investment Management LLC now owns 6,418 shares of the business services provider’s stock worth $490,000 after buying an additional 70 shares during the last quarter. Gofen & Glossberg LLC IL raised its stake in shares of Stericycle by 0.4% during the 2nd quarter. Gofen & Glossberg LLC IL now owns 63,691 shares of the business services provider’s stock worth $4,861,000 after buying an additional 225 shares during the last quarter. Raymond James Financial Services Advisors Inc. raised its stake in shares of Stericycle by 2.6% during the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 14,593 shares of the business services provider’s stock worth $1,114,000 after buying an additional 371 shares during the last quarter. Community Financial Services Group LLC raised its stake in shares of Stericycle by 1.5% during the 4th quarter. Community Financial Services Group LLC now owns 53,975 shares of the business services provider’s stock worth $3,669,000 after buying an additional 795 shares during the last quarter. Finally, Armstrong Henry H Associates Inc. raised its stake in shares of Stericycle by 6.9% during the 4th quarter. Armstrong Henry H Associates Inc. now owns 12,830 shares of the business services provider’s stock worth $872,000 after buying an additional 830 shares during the last quarter. 95.92% of the stock is owned by institutional investors and hedge funds.
In related news, Director Mark C. Miller sold 19,753 shares of the business’s stock in a transaction dated Monday, November 27th. The shares were sold at an average price of $63.33, for a total value of $1,250,957.49. Following the completion of the transaction, the director now owns 205,854 shares of the company’s stock, valued at approximately $13,036,733.82. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders sold a total of 59,259 shares of company stock valued at $3,847,687 in the last three months. 3.50% of the stock is currently owned by corporate insiders.
Stericycle (NASDAQ:SRCL) last announced its earnings results on Wednesday, November 8th. The business services provider reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.14 by ($0.04). Stericycle had a negative net margin of 0.79% and a positive return on equity of 13.93%. The firm had revenue of $883.00 million during the quarter, compared to analyst estimates of $896.81 million. During the same period in the previous year, the firm posted $1.24 EPS. The company’s revenue for the quarter was down .8% compared to the same quarter last year. equities analysts expect that Stericycle Inc will post 4.49 earnings per share for the current fiscal year.
Several research firms have recently issued reports on SRCL. BidaskClub raised Stericycle from a “sell” rating to a “hold” rating in a research note on Wednesday, January 31st. Zacks Investment Research raised Stericycle from a “sell” rating to a “hold” rating in a research note on Wednesday, January 10th. Royal Bank of Canada lifted their price target on Stericycle to $75.00 and gave the stock an “underperform” rating in a research note on Friday, January 19th. Barrington Research cut their price target on Stericycle from $87.00 to $75.00 and set an “outperform” rating for the company in a research note on Friday, November 10th. Finally, BMO Capital Markets reaffirmed a “hold” rating and set a $72.00 price target on shares of Stericycle in a research note on Wednesday, January 24th. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and five have given a buy rating to the company. Stericycle currently has a consensus rating of “Hold” and an average target price of $73.70.
COPYRIGHT VIOLATION WARNING: This news story was originally published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright law. The original version of this news story can be read at https://sportsperspectives.com/2018/02/09/boston-family-office-llc-cuts-stake-in-stericycle-inc-srcl.html.
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.